Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
ALGN's Cash to Debt is ranked higher than
98% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. ALGN: No Debt )
Ranked among companies with meaningful Cash to Debt only.
ALGN' s Cash to Debt Range Over the Past 10 Years
Min: 5.57  Med: 10000.00 Max: No Debt
Current: No Debt
Equity to Asset 0.74
ALGN's Equity to Asset is ranked higher than
67% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. ALGN: 0.74 )
Ranked among companies with meaningful Equity to Asset only.
ALGN' s Equity to Asset Range Over the Past 10 Years
Min: 0.55  Med: 0.76 Max: 0.89
Current: 0.74
0.55
0.89
Interest Coverage No Debt
ALGN's Interest Coverage is ranked higher than
96% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 481.81 vs. ALGN: No Debt )
Ranked among companies with meaningful Interest Coverage only.
ALGN' s Interest Coverage Range Over the Past 10 Years
Min: 22.24  Med: 3589.41 Max: 9999.99
Current: No Debt
22.24
9999.99
F-Score: 5
Z-Score: 13.01
M-Score: -2.80
WACC vs ROIC
10.87%
43.50%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 22.22
ALGN's Operating margin (%) is ranked higher than
91% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.89 vs. ALGN: 22.22 )
Ranked among companies with meaningful Operating margin (%) only.
ALGN' s Operating margin (%) Range Over the Past 10 Years
Min: -18.19  Med: 13.09 Max: 26.54
Current: 22.22
-18.19
26.54
Net-margin (%) 16.55
ALGN's Net-margin (%) is ranked higher than
86% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 0.95 vs. ALGN: 16.55 )
Ranked among companies with meaningful Net-margin (%) only.
ALGN' s Net-margin (%) Range Over the Past 10 Years
Min: -16.94  Med: 11.52 Max: 26.31
Current: 16.55
-16.94
26.31
ROE (%) 17.55
ALGN's ROE (%) is ranked higher than
87% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. ALGN: 17.55 )
Ranked among companies with meaningful ROE (%) only.
ALGN' s ROE (%) Range Over the Past 10 Years
Min: -39.51  Med: 13.16 Max: 42.13
Current: 17.55
-39.51
42.13
ROA (%) 13.28
ALGN's ROA (%) is ranked higher than
91% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: -0.07 vs. ALGN: 13.28 )
Ranked among companies with meaningful ROA (%) only.
ALGN' s ROA (%) Range Over the Past 10 Years
Min: -23.81  Med: 10.10 Max: 31.86
Current: 13.28
-23.81
31.86
ROC (Joel Greenblatt) (%) 174.60
ALGN's ROC (Joel Greenblatt) (%) is ranked higher than
98% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. ALGN: 174.60 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ALGN' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -126.9  Med: 125.09 Max: 369.18
Current: 174.6
-126.9
369.18
Revenue Growth (3Y)(%) 15.80
ALGN's Revenue Growth (3Y)(%) is ranked higher than
86% of the 209 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. ALGN: 15.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ALGN' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.6  Med: 15.40 Max: 144.4
Current: 15.8
7.6
144.4
EBITDA Growth (3Y)(%) 24.20
ALGN's EBITDA Growth (3Y)(%) is ranked higher than
84% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. ALGN: 24.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ALGN' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -35.2  Med: 23.15 Max: 44.9
Current: 24.2
-35.2
44.9
EPS Growth (3Y)(%) 28.70
ALGN's EPS Growth (3Y)(%) is ranked higher than
78% of the 187 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. ALGN: 28.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ALGN' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -76.1  Med: 5.15 Max: 276.6
Current: 28.7
-76.1
276.6
» ALGN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

ALGN Guru Trades in Q1 2015

Steven Cohen 1,019,021 sh (+1451.02%)
Joel Greenblatt 45,553 sh (+53.29%)
Jim Simons 172,179 sh (+20.67%)
Columbia Wanger 584,000 sh (+18.46%)
Paul Tudor Jones 9,374 sh (+9.48%)
Ken Fisher 10,528 sh (unchged)
Mario Gabelli 9,000 sh (unchged)
Ron Baron 27,500 sh (unchged)
Chuck Royce Sold Out
Pioneer Investments 284,250 sh (-4.81%)
Mariko Gordon 81,033 sh (-13.27%)
» More
Q2 2015

ALGN Guru Trades in Q2 2015

Jim Simons 351,981 sh (+104.43%)
Columbia Wanger 868,077 sh (+48.64%)
Pioneer Investments 293,280 sh (+3.18%)
Ron Baron 27,500 sh (unchged)
Ken Fisher 10,528 sh (unchged)
Mariko Gordon 80,138 sh (-1.10%)
Mario Gabelli 8,000 sh (-11.11%)
Paul Tudor Jones 5,981 sh (-36.20%)
Joel Greenblatt 4,540 sh (-90.03%)
Steven Cohen 77,700 sh (-92.38%)
» More
Q3 2015

ALGN Guru Trades in Q3 2015

RS Investment Management 201,638 sh (New)
Ruane Cunniff 70,747 sh (New)
Ray Dalio 8,300 sh (New)
Steven Cohen 479,200 sh (+516.73%)
Ken Fisher 16,578 sh (+57.47%)
Columbia Wanger 1,232,490 sh (+41.98%)
Pioneer Investments 398,086 sh (+35.74%)
Joel Greenblatt 4,600 sh (+1.32%)
Ron Baron 27,500 sh (unchged)
Paul Tudor Jones Sold Out
Mariko Gordon 74,110 sh (-7.52%)
Mario Gabelli 6,000 sh (-25.00%)
Jim Simons 249,800 sh (-29.03%)
» More
Q4 2015

ALGN Guru Trades in Q4 2015

Ken Fisher 111,781 sh (+574.27%)
Columbia Wanger 2,942,240 sh (+138.72%)
Mario Gabelli 6,000 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with ALGN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 36.83
ALGN's P/E(ttm) is ranked lower than
65% of the 255 Companies
in the Global Medical Devices industry.

( Industry Median: 28.18 vs. ALGN: 36.83 )
Ranked among companies with meaningful P/E(ttm) only.
ALGN' s P/E(ttm) Range Over the Past 10 Years
Min: 5.22  Med: 32.15 Max: 405.23
Current: 36.83
5.22
405.23
Forward P/E 21.98
ALGN's Forward P/E is ranked lower than
67% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 18.18 vs. ALGN: 21.98 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 36.93
ALGN's PE(NRI) is ranked lower than
65% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 28.18 vs. ALGN: 36.93 )
Ranked among companies with meaningful PE(NRI) only.
ALGN' s PE(NRI) Range Over the Past 10 Years
Min: 5.21  Med: 32.18 Max: 445.75
Current: 36.93
5.21
445.75
P/B 6.08
ALGN's P/B is ranked lower than
95% of the 384 Companies
in the Global Medical Devices industry.

( Industry Median: 2.50 vs. ALGN: 6.08 )
Ranked among companies with meaningful P/B only.
ALGN' s P/B Range Over the Past 10 Years
Min: 1.86  Med: 4.89 Max: 15.9
Current: 6.08
1.86
15.9
P/S 6.11
ALGN's P/S is ranked lower than
90% of the 386 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. ALGN: 6.11 )
Ranked among companies with meaningful P/S only.
ALGN' s P/S Range Over the Past 10 Years
Min: 1.31  Med: 4.14 Max: 7.94
Current: 6.11
1.31
7.94
PFCF 26.76
ALGN's PFCF is ranked higher than
63% of the 199 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. ALGN: 26.76 )
Ranked among companies with meaningful PFCF only.
ALGN' s PFCF Range Over the Past 10 Years
Min: 11.21  Med: 23.29 Max: 2846
Current: 26.76
11.21
2846
POCF 21.57
ALGN's POCF is ranked lower than
53% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 20.00 vs. ALGN: 21.57 )
Ranked among companies with meaningful POCF only.
ALGN' s POCF Range Over the Past 10 Years
Min: 8.39  Med: 19.09 Max: 338.5
Current: 21.57
8.39
338.5
EV-to-EBIT 24.14
ALGN's EV-to-EBIT is ranked higher than
55% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 23.94 vs. ALGN: 24.14 )
Ranked among companies with meaningful EV-to-EBIT only.
ALGN' s EV-to-EBIT Range Over the Past 10 Years
Min: -378.4  Med: 21.90 Max: 161.1
Current: 24.14
-378.4
161.1
EV-to-EBITDA 22.04
ALGN's EV-to-EBITDA is ranked lower than
60% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 17.27 vs. ALGN: 22.04 )
Ranked among companies with meaningful EV-to-EBITDA only.
ALGN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -248.4  Med: 18.60 Max: 578.7
Current: 22.04
-248.4
578.7
Shiller P/E 81.90
ALGN's Shiller P/E is ranked lower than
86% of the 71 Companies
in the Global Medical Devices industry.

( Industry Median: 31.42 vs. ALGN: 81.90 )
Ranked among companies with meaningful Shiller P/E only.
ALGN' s Shiller P/E Range Over the Past 10 Years
Min: 73.35  Med: 101.87 Max: 544.4
Current: 81.9
73.35
544.4
Current Ratio 2.91
ALGN's Current Ratio is ranked higher than
54% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.66 vs. ALGN: 2.91 )
Ranked among companies with meaningful Current Ratio only.
ALGN' s Current Ratio Range Over the Past 10 Years
Min: 1.59  Med: 3.00 Max: 6.96
Current: 2.91
1.59
6.96
Quick Ratio 2.83
ALGN's Quick Ratio is ranked higher than
64% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. ALGN: 2.83 )
Ranked among companies with meaningful Quick Ratio only.
ALGN' s Quick Ratio Range Over the Past 10 Years
Min: 1.55  Med: 2.92 Max: 6.82
Current: 2.83
1.55
6.82
Days Inventory 30.50
ALGN's Days Inventory is ranked higher than
92% of the 281 Companies
in the Global Medical Devices industry.

( Industry Median: 142.23 vs. ALGN: 30.50 )
Ranked among companies with meaningful Days Inventory only.
ALGN' s Days Inventory Range Over the Past 10 Years
Min: 9.28  Med: 16.75 Max: 32.75
Current: 30.5
9.28
32.75
Days Sales Outstanding 66.56
ALGN's Days Sales Outstanding is ranked higher than
56% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 72.25 vs. ALGN: 66.56 )
Ranked among companies with meaningful Days Sales Outstanding only.
ALGN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.64  Med: 62.40 Max: 69.64
Current: 66.56
51.64
69.64
Days Payable 76.75
ALGN's Days Payable is ranked higher than
59% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 59.85 vs. ALGN: 76.75 )
Ranked among companies with meaningful Days Payable only.
ALGN' s Days Payable Range Over the Past 10 Years
Min: 14.24  Med: 39.37 Max: 68.75
Current: 76.75
14.24
68.75

Valuation & Return

vs
industry
vs
history
Price/Net Cash 22.91
ALGN's Price/Net Cash is ranked lower than
72% of the 148 Companies
in the Global Medical Devices industry.

( Industry Median: 12.29 vs. ALGN: 22.91 )
Ranked among companies with meaningful Price/Net Cash only.
ALGN' s Price/Net Cash Range Over the Past 10 Years
Min: 2.22  Med: 18.95 Max: 417
Current: 22.91
2.22
417
Price/Net Current Asset Value 10.84
ALGN's Price/Net Current Asset Value is ranked lower than
68% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 6.22 vs. ALGN: 10.84 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ALGN' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.74  Med: 8.27 Max: 25.8
Current: 10.84
1.74
25.8
Price/Tangible Book 6.50
ALGN's Price/Tangible Book is ranked lower than
67% of the 383 Companies
in the Global Medical Devices industry.

( Industry Median: 4.18 vs. ALGN: 6.50 )
Ranked among companies with meaningful Price/Tangible Book only.
ALGN' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.17  Med: 5.74 Max: 16.53
Current: 6.5
1.17
16.53
Price/Projected FCF 1.87
ALGN's Price/Projected FCF is ranked higher than
51% of the 219 Companies
in the Global Medical Devices industry.

( Industry Median: 1.87 vs. ALGN: 1.87 )
Ranked among companies with meaningful Price/Projected FCF only.
ALGN' s Price/Projected FCF Range Over the Past 10 Years
Min: 1.38  Med: 2.21 Max: 14.76
Current: 1.87
1.38
14.76
Price/Median PS Value 1.42
ALGN's Price/Median PS Value is ranked lower than
78% of the 386 Companies
in the Global Medical Devices industry.

( Industry Median: 0.98 vs. ALGN: 1.42 )
Ranked among companies with meaningful Price/Median PS Value only.
ALGN' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.43  Med: 1.02 Max: 8.03
Current: 1.42
0.43
8.03
Price/Peter Lynch Fair Value 2.32
ALGN's Price/Peter Lynch Fair Value is ranked higher than
77% of the 70 Companies
in the Global Medical Devices industry.

( Industry Median: 2.53 vs. ALGN: 2.32 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
ALGN' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.57  Med: 2.13 Max: 14.72
Current: 2.32
0.57
14.72
Price/Graham Number 3.20
ALGN's Price/Graham Number is ranked lower than
58% of the 268 Companies
in the Global Medical Devices industry.

( Industry Median: 2.81 vs. ALGN: 3.20 )
Ranked among companies with meaningful Price/Graham Number only.
ALGN' s Price/Graham Number Range Over the Past 10 Years
Min: 0.83  Med: 3.05 Max: 17.76
Current: 3.2
0.83
17.76
Earnings Yield (Greenblatt) (%) 4.10
ALGN's Earnings Yield (Greenblatt) (%) is ranked higher than
69% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 0.70 vs. ALGN: 4.10 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ALGN' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.6  Med: 4.20 Max: 9.7
Current: 4.1
0.6
9.7
Forward Rate of Return (Yacktman) (%) 18.00
ALGN's Forward Rate of Return (Yacktman) (%) is ranked higher than
89% of the 108 Companies
in the Global Medical Devices industry.

( Industry Median: 5.28 vs. ALGN: 18.00 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ALGN' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -10  Med: 2.50 Max: 23.8
Current: 18
-10
23.8

More Statistics

Revenue(Mil) $814
EPS $ 1.65
Beta1.20
Short Percentage of Float7.31%
52-Week Range $51.65 - 69.36
Shares Outstanding(Mil)79.49

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 845 1,033
EPS($) 1.64 2.15 2.67
EPS without NRI($) 1.64 2.15 2.67

Latest Earnings Webcast

» More Conference Calls

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:AFW.Germany,
Align Technology Inc was founded in March 1997 and incorporated in Delaware in April 1997. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The Company has two operating segments: Clear Aligner segment and SCCS segment. Its Clear Aligner segment consists of its Invisalign System which includes Invisalign Full, Express/Lite, Teen, Assist, Vivera Retainers, along with its training and ancillary products for treating malocclusion. The SCCS segment consists of intra-oral scanning systems, and additional services available with the intra-oral scanners, that provide digital alternatives to the traditional cast models. This segment includes its iTero scanner and OrthoCAD services. The Company distributes its products directly to its customers: orthodontists and general practitioner dentists as well as to restorative dentists, including prosthodontists, periodontists, and oral surgeons. The Companys manufacturing facilities are located in Juarez, Mexico, where it conduct its aligner fabrication, distribute and repair its scanners, perform its CAD/CAM services, and in Or Yehuda, Israel where it produce its handheld intra-oral scanner wand. As of December 31, 2013, the Company had 313 issued U.S. patents, 124 pending U.S. patent applications, and 239 foreign issued patents, as well as 116 pending foreign patent applications. Its trademarks include Invisalign, Align, ClinCheck, Invisalign Assist, Invisalign Teen, Vivera, SmartForce, SmartTrack, Power Ridge and iTero. The Company competes with Danaher Corporation, 3M, Sirona Dental Systems, Inc., Dentsply International, Inc. and among others. The Company is subject to various laws inside and outside the U.S. concerning its relationships with healthcare professionals and government officials, price reporting and regulation, the promotion, sales and marketing of its products and services, the importation and exportation of its products, the operation of its facilities and distribution of its products. It is also subject to varying degrees of government regulation in the various countries in which the Company do business.
» More Articles for ALGN

Headlines

Articles On GuruFocus.com
Ruane Cunniff's Top New Buys of 3rd Quarter Dec 15 2015 
Valeant Top Shareholder Sequoia Fund's Largest New Buys Nov 19 2015 
Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables Aug 11 2014 
WEEKLY CFO SELLS HIGHLIGHT: CY, UTEK, STJ, ALGN, TXN, JAH, YUM May 01 2011 
Align Technologies Takes One in the Teeth Apr 06 2010 
Weekly CEO Sells Highlight: Rockwell Automation Inc. Common, Penske Automotive Group Inc., Align Tec Feb 07 2010 
Align Technology Inc. (ALGN) President and CEO Thomas M Prescott sells 328,596 Shares Feb 03 2010 

More From Other Websites
Should These Companies’ Insider Selling Alarm Investors? Feb 08 2016
Align Technology to Present at Upcoming Financial Conference Feb 05 2016
ALIGN TECHNOLOGY INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 05 2016
Align Technology Announces Commercial Availability of the Invisalign System in India Feb 05 2016
Align Technology, Inc. Earnings Analysis: Q4, 2015 By the Numbers Feb 02 2016
Align Technology, Inc.: Leads amongst peers with strong fundamentals Feb 01 2016
Align Technology, Inc. breached its 50 day moving average in a Bullish Manner : February 1, 2016 Feb 01 2016
Align Technology (ALGN) Looks Good: Stock Gains 11.1% Feb 01 2016
Align Technology Tops Q4 Earnings, Revenues; Margins Drop Jan 29 2016
Edited Transcript of ALGN earnings conference call or presentation 28-Jan-16 9:30pm GMT Jan 29 2016
Align Technology beats Street 4Q forecasts Jan 28 2016
Align Technology beats Street 4Q forecasts Jan 28 2016
Align Technology Announces Fourth Quarter and 2015 Results Jan 28 2016
ALIGN TECHNOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition Jan 28 2016
Align Technology Announces Fourth Quarter and 2015 Results Jan 28 2016
Q4 2015 Align Technology Inc Earnings Release - 4:00 pm ET Jan 28 2016
GlucoTrack® Maker Hires Chief Operating Officer Jan 12 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK